Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Deborah L Lu"'
Publikováno v:
Pharmaceutical Patent Analyst. 2:1-3
1Vedder Price PC, 1633 Broadway, NY 10019, USA 2Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, NJ 07110, USA *Author for correspondence: E-mail: dlu@vedderprice.com The attorney–client privilege protects confidential communication between a
Publikováno v:
Pharmaceutical patent analyst. 1(2)
Vedder Price PC, 1633 Broadway, 47th Floor, New York, NY 10019, USA *Author for correspondence: E-mail: suthaman@vedderprice.com “Nothing is permanent except change.” Heraclitus of Ephesus c. 535–475 BC. US patent law has its foundation in the
Autor:
Deborah L. Lu, K. M. J. Menon
Publikováno v:
Biochemistry. 35:12347-12353
Multiple luteinizing hormone/human chorionic gonadotropin (LH/hCG) receptor mRNAs (6.7, 4.4, 2.6, and 1.8 kb) have been identified in the rat ovary. Our laboratory has previously cloned a 3.5 kb cDNA that corresponds to the 3' untranslated region (3'
Publikováno v:
Journal of Commercial Biotechnology. 18
The importance of laboratory notebooks was long touted in the US to prove a date of invention. With the dawning of a first-to-file era in the US, the importance of laboratory notebooks has been questioned. A perspective on the importance of laborator
Publikováno v:
Future medicinal chemistry. 3(7)
Publikováno v:
Future medicinal chemistry. 2(1)
Publikováno v:
Endocrinology. 132:235-240
Previous studies have demonstrated that ligand-induced down-regulation of the LH/hCG receptor in rat corpus luteum results in a loss of ligand-binding activity and a parallel decline in steady state levels of receptor mRNA. The purpose of the present
Publikováno v:
Journal of Commercial Biotechnology. 16:360-361
 Â
Autor:
Deborah L Lu, Thomas J Kowalski
Publikováno v:
Journal of Commercial Biotechnology. 16:277-278
Publikováno v:
Nature Biotechnology. 25:1403-1404
Although increased patenting has accompanied the development of antivirals as in vivo therapeutics, ongoing US litigation reflects concerns regarding their patentability.